Monday, January 29, 2018 10:19:59 AM
In his SEC filings, Tenax’s CEO & CFO Michael B. Jebsen states that Tenax is not developing Oxycyte (a PFC product), and that Oxycyte is of no importance for the future business. SEC FORM 10-K Commission File No. 001-34600 reads as follows: “As we have suspended the development of these PFC products (…), we do not expect that Oxycyte, Dermacyte or Wundecyte constitute a material portion of our business going forward.” In strong contrast to this SEC filing, several Scottish State institutions confirm, that a huge development project for Oxycyte has been underway for years. To push forward the joint development of Oxycyte, Tenax Therapeutics and Aurum Biosciences (a research company near the Scottish State) set up a major research, development and commercialization deal (details: www.aurumbiosciences.com > Investor Information). In Q1 2018, the two companies are going to take their development project into a phase 2a trial (www.aurumbiosciences.com > news). Important Scottish State institutions are involved:
1-The Scottish Parliament gave it’s backing to the joint development activities of Tenax and Aurum. Parliament motion S4M-14835 states that the Scottish Parliament “encourages the continued relationship between Aurum Biosciences and Tenax Therapeutics to provide for Aurum Biosciences to further develop Oxycyte.” (for details go to my posting #7583)
2-The University of Glasgow confirms that £1,816,033 in funding is in place for the years 2017-2018 designated to the following project: “GOLD imaging in acute stroke: further technology development incorporating a perfluorocarbon oxygen carrier (Oxycyte).” (Google the following words: “GEMRIC grant funding oxycyte”).
3-The Scottish Wellcome Trust lists among the projects that receive it’s funding the following project: “GOLD imaging in acute stroke: further technology development incorporating a perfluorocarbon oxygen carrier (Oxycyte)”. (https://wellcome.ac.uk/what-we-do/directories/health-innovation-challenge-fund-projects-funded)
Aurum is nexus between Tenax and Scottish State
Let’s therefore have a quick look at these Scottish State institutions and their role in the joint Tenax-Aurum development project for Oxycyte.
Over the last few years, the Scottish State has built a new MRI Centre, the Imaging Centre of Excellence (ICE). The £32million ICE facilities offer modern medical imaging technology, most notably in the area of brain imaging, and are connected to the £1billion Queen Elizabeth University Hospital (QEUH) in Glasgow, the largest acute hospital in Western Europe. The Centre’s facilities include a £10million, ultra-high resolution 7T MRI scanner. The most important research project at the ICE is led by Aurum Biosciences - a spin-out from NHS Greater Glasgow & Clyde and the University of Glasgow. Aurum received funding of over £3million mostly form the Scottish Wellcome Trust to develop a new stroke imaging therapy based on Oxycyte. Aurum was set up as a private company, largely because it is not possible to directly use Scottish state money for the development of a privately-owned drug like Oxycyte. Aurum is thus primarily a legal framework, that makes it possible for the Scottish State to invest money into the development of an Oxycyte based therapy - the “real” partners of Tenax being, of course, not Aurum but the ICE, QEUH, NHS Greater Glasgow & Clyde, Scottish Wellcome Trust and the University of Glasgow. That’s why the Scottish Parliament takes such a keen interest in the Tenax-Aurum development deal for Oxycyte (see my posting #7583): Scottish state money is at stake!
Are the Scottish State institutions to help with the SEC?
And now we are faced with a tricky problem. The Scottish State probably does not want to be caught – well, how shall one put it without becoming ironical – in bed with something that might be mistaken for a whore or a thief – if officially investigated. No, no, no! Instead, the Scottish State probably wants its partners to be neat and tidy. But as long as Tenax's CEO Michael B. Jebsen goes on producing SEC filings that maintain that no joint Tenax-Aurum development project is taking place, and that Oxycyte does not represent a material portion of Tenax’s business going forward, an investigation might be triggered. Such an investigation could – albeit nobody who knows Michael B. Jebsen well, would consider that a possible outcome - bring to light some forgetfulness or even untidiness. Furthermore, it must look strange to the Scotsmen that their long development partnership with Tenax does not show up on Tenax’s homepage anymore, simply because Mr. Jebsen deleted that information shortly after Aurum announced the upcoming phase 2a trial with Oxycyte. To find the deleted information, use Google with the words “Tenax, Pipeline, Oxycyte” and hit the cache button. Thus, the Scottish State institutions probably and possibly are beginning to think about how they could best help Michael B. Jebsen to make the scent of his company's SEC statements more shining, fresh and fragrant. Being generous people, the Scotsmen are likely to grant Mr. Jebsen much more help than just providing him with a new toothbrush.
Recent TENX News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2024 04:15:07 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/12/2024 08:15:28 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/10/2024 09:19:47 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/30/2024 08:20:02 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/19/2024 10:48:03 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/19/2024 08:15:15 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/15/2024 08:19:12 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/14/2024 10:47:35 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/14/2024 07:19:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:45:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:30:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:35:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 11:43:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 11:42:23 PM
- Biotech Soars Following Oversubscribed $100M Private Placement Announcement • AllPennyStocks.com • 08/06/2024 08:55:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:23:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:32:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:01:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:00:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:01:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:01:43 PM
- Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update • GlobeNewswire Inc. • 05/14/2024 12:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM